WIN Backs SonoVascular Ahead of Clinical Trials

Research Triangle Park medical company SonoVascular is one step closer to improving treatment for those with venous thromboembolism after securing capital and resources from the Wolfpack Investor Network.

The Wolfpack Investor Network (WIN) announced its newest investment in SonoVascular, an early-stage medical device company that offers a novel approach for the treatment of pulmonary embolism and deep vein thrombosis caused by blood clots in the lungs or legs.